Back to all news
ECR 2026: Radiologists Push for Stronger Evidence and EU Support in Imaging AI
Tags:Policy
European radiologists at ECR 2026 call for more resources to achieve strong evidence and societal impact for radiology AI, especially under new EU HTA regulation.
Key Details
- 1Radiologists highlight the need for national or EU funding to achieve robust evidence for AI applications.
- 2Current studies on radiology AI are predominantly small and retrospective due to resource constraints.
- 3The new EU Health Technology Assessment (HTA) regulation began Jan 12, 2025, aiming to standardize evaluation and reimbursement decisions.
- 4Radiologists are increasingly expected to generate evidence on clinical utility, patient outcomes, cost-effectiveness, and system impact.
- 5Joint Clinical Assessments (JCAs) for medical devices, including radiology AI, will be selected starting June 2026.
- 6Improved collaboration and feedback loops between radiologists, industry, and HTA bodies are deemed essential for valuable AI adoption.
Why It Matters
The shift to HTA-driven evaluation could greatly influence how imaging AI is adopted and reimbursed across the EU, making it vital for radiologists to actively participate in evidence generation and regulatory processes. This development may affect AI deployment, clinical impact, and patient care standards in European radiology.
Source
AuntMinnie
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.
•HealthExec
AI's Role in Eliminating Cervical Cancer: A Model for Disease Prevention
Researchers highlight how AI can accelerate the elimination of cervical cancer and set a precedent for combating other diseases.